Increasing Human Papillomavirus Vaccination Among Young Gay and Bisexual Men: A Randomized Pilot Trial of the Outsmart HPV Intervention

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Purpose: The study purpose was to pilot test a web-based human papillomavirus (HPV) vaccination intervention among young gay and bisexual men (YGBM). Methods: In 2016, we recruited 150 unvaccinated YGBM aged 18–25 years from the United States. We randomized participants to the Outsmart HPV intervention or a control group. Results: HPV vaccine initiation was higher among the intervention group than the control group (45% vs. 26%; odds ratio [OR] = 2.34, 95% confidence interval [CI]: 1.18–4.67). We observed a trend toward higher HPV vaccine completion among the intervention group (11% vs. 3%; OR = 4.24, 95% CI: 0.87–20.66). Conclusions: Outsmart HPV is a promising strategy for increasing HPV vaccination among YGBM.

Related collections

Most cited references 9

Record: found
Abstract: found
Article: not found

Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?

G Euler, Megan Parker, T Kerby … (2013)

Immunizations are crucial to the prevention of disease, thus, having an accurate measure of vaccination status for a population is an important guide in targeting prevention efforts. In order to comprehensively assess the validity of self-reported adult vaccination status for the eight most common adult vaccines we conducted a survey of vaccination receipt and compared it to the electronic medical record (EMR), which was used as the criterion standard, in a population of community-dwelling patients in a large healthcare system. In addition, we assessed whether validity varied by demographic factors. The vaccines included: pneumococcal (PPSV), influenza (Flu), tetanus diphtheria (Td), tetanus diphtheria pertussis (Tdap), Human Papilloma Virus (HPV), hepatitis A (HepA), hepatitis B (HepB) and herpes zoster (shingles). Telephone surveys were conducted with 11,760 individuals, ≥18, half with documented receipt of vaccination and half without. We measured sensitivity, specificity, positive and negative predictive value, net bias and over- and under-reporting of vaccination. Variation was found across vaccines, however, sensitivity and specificity did not vary substantially by either age or race/ethnicity. Sensitivity ranged between 63% for HepA to over 90% (tetanus, HPV, shingles and Flu). Hispanics were 2.7 times more likely to claim receipt of vaccination compared to whites. For PPSV and Flu those 65+ had low specificity compared to patients of younger ages while those in the youngest age group had lowest specificity for HepA and HepB. In addition to racial/ethnic differences, over-reporting was more frequent in those retired and those with household income less than $75,000. Accurate information for vaccination surveillance is important to estimate progress toward vaccination coverage goals and ensure appropriate policy decisions and allocation of resources for public health. It was clear from our findings that EMR and self-report do not always agree. Finding approaches to improve both EMR data capture and patient awareness would be beneficial. Copyright © 2013 Elsevier Ltd. All rights reserved.

0 comments Cited 73 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Predictors of Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men.

Mary A. Gerend, Krystal Madkins, Gregory Phillips … (2016)

Human papillomavirus (HPV) is a common sexually transmitted infection that causes anal, penile, and oropharyngeal cancers in men. Men who have sex with men (MSM) are at particularly high risk for HPV infection and HPV-related disease. Human papillomavirus vaccination is currently recommended for all MSM in the United States through age 26 years, yet little is known about HPV vaccine uptake in this population. The purpose of this study was to identify predictors of HPV vaccine uptake and barriers and facilitators to HPV vaccination that may be unique to young MSM.

0 comments Cited 50 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses.

A. Léonard, Keith Marsolo, Lea Widdice … (2010)

The objectives of this study were to determine (1) adherence to the immunization schedule for the human papillomavirus quadrivalent vaccine and (2) factors associated with completion of the 3-dose series. This was a retrospective review of health information records from an academic medical center. The sample included all 9- to 26-year-old female patients who initiated vaccination within 2 years after quadrivalent vaccine availability. Multivariable logistic regression models were estimated to determine associations with completion of the 3-dose series within 7 and 12 months. Among the 3297 female patients who initiated vaccination with human papillomavirus quadrivalent vaccine, 67% self-identified as black and 29% self-identified as white. Fewer than 3% of vaccine doses were received earlier than recommended, but >50% of doses were received late. Completion rates were 14% by 7 months and 28% by 12 months. Independent predictors of completion by 7 months included white versus black race (odds ratio [OR]: 2.04 [95% confidence interval (CI): 1.64-2.56]; P < .001), use of contraception that required intramuscular injections every 3 months (OR: 1.53 [95% CI: 1.12-1.95]; P < .001), and private versus public insurance (OR: 1.31 [95% CI: 1.06-1.63]; P < .05). Age and clinic type were not independent predictors of completion. Adherence to recommended intervals and completion of the vaccine series were low. Lower rates of completion in black patients compared with white patients raises concern that disparities in vaccine completion could exacerbate existing disparities in cervical cancer.

0 comments Cited 37 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Title: LGBT Health

Abbreviated Title: LGBT Health

Publisher: Mary Ann Liebert Inc

ISSN (Print): 2325-8292

ISSN (Electronic): 2325-8306

Publication date Created: July 2018

Publication date (Print): July 2018

Volume: 5

Issue: 5

Pages: 325-329

Affiliations

[1 ]Division of Cancer Prevention and Control, College of Medicine, The Ohio State University, Columbus, Ohio.

[2 ]Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

[3 ]College of Public Health, The Ohio State University, Columbus, Ohio.

[4 ]Department of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.

[5 ]Division of General Pediatrics and Adolescent Health, University of Minnesota Medical School, Minneapolis, Minnesota.

Article

DOI: 10.1089/lgbt.2018.0059

PMC ID: 6034390

PubMed ID: 29979642

SO-VID: 83e07e42-a133-4036-bd8e-677a7e85c483

License:

http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 23

See all cited by

Most referenced authors 144

See all reference authors

- Version 1

Increasing Human Papillomavirus Vaccination Among Young Gay and Bisexual Men: A Randomized Pilot Trial of the Outsmart HPV Intervention

Read this article at

Abstract

Related collections

Clinical Social Work and Health Intervention

Most cited references 9

Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?

Predictors of Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men.

Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses.

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 1,179

Cited by 23

Most referenced authors 144